Cerulean Pharma reported $16.4M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US 9.72M 3.86M
Agile Therapeutics AGRX:US $ 28.78M 2.93M
Arrowhead Research ARWR:US $ 128.21M 10.64M
Bayer BAYN:GR € 33643M 2624M
Biocept BIOC:US $ 14.1M 2.32M
Brainstorm Cell Therapeutics BCLI:US $ 7.85M 0.47M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Immunogen IMGN:US $ 87.07M 2.95M
Macrogenics MGNX:US $ 50.88M 16.22M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Seattle Genetics SGEN:US $ 608.52M 77.23M
YTE INCY:US $ 926.67M 40.51M